Natco vs Novo Nordisk: Delhi High Court Directs Mediation in Wegovy Patent Dispute Farhat Nasim21 Aug 2025 9:26 PM ISTNew Delhi: Hyderabad-based Natco Pharma has filed a lawsuit against Danish drugmaker Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy...
Rs 180 Crore Ozempic Fraud: LOC Issued Against Pharma Firm CEO Parthika Patel20 Aug 2025 7:41 PM ISTNew Delhi: Delhi Police has issued a lookout circular (LOC) against Vicky Ramancha, Chief Executive Officer (CEO) of a pharmaceutical company, for...
Novo Nordisk Wegovy approved by USFDA for adults with noncirrhotic MASH with liver fibrosis Ruchika Sharma16 Aug 2025 12:45 PM ISTPlainsboro: Novo Nordisk has received approval from the US Food and Drug Administration (FDA) for a new indication for Wegovy...
Emcure Pharma Gets CDSCO Panel Nod for Phase III Trial of Semaglutide in Chronic Weight Management Susmita Roy13 Aug 2025 5:39 PM ISTNew Delhi: Accepting the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Precise Biopharma Gets CDSCO Panel Nod To Conduct Phase III Trial of Semaglutide Injection Susmita Roy12 Aug 2025 12:47 PM ISTNew Delhi: Accepting the bioequivalence study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Tirzepatide superior to Semaglutide- SURMOUNT-5 Trial Results Deeksha Bhandari11 Aug 2025 12:54 PM IST In SURMOUNT-5 Treatment with tirzepatide MTD (10 or 15 mg) was superior to semaglutide MTD (1.7 or 2.4 mg) with respect to reduction in...
Indian pharma market registers 7.9 percent growth in July: Report MD Bureau9 Aug 2025 3:30 PM ISTNew Delhi: The Indian pharmaceutical market (IPM) registered a growth of 7.9 percent in July 2025, and cardiac and anti-diabetes therapy segments have...
CDSCO Panel Approves New Indications for Novo Nordisk's Semaglutide, Mandates PMS Study Susmita Roy9 Aug 2025 12:18 PM ISTNew Delhi: Recommending to conduct post marketing surveillance (PMS) study in India, the Subject Expert Committee (SEC) functional under the Central...
Torrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: Report Farhat Nasim29 July 2025 10:09 PM ISTNew Delhi: Torrent Pharmaceuticals is preparing to introduce both oral and injectable versions of Semaglutide, a blockbuster diabetes and weight loss...
Dr Reddy's Labs plans to roll out cheaper Wegovy copycat across 87 countries in 2026: CEO Ruchika Sharma25 July 2025 4:30 PM ISTHyderabad: Dr. Reddy's Laboratories is gearing up to shake up the global weight-loss drug market with the launch of an affordable copycat version...
Once-Weekly Semaglutide-Insulin Combo Matches Daily Basal-Bolus in Type 2 Diabetes Control: Study Dr Riya Dave25 July 2025 9:30 AM ISTAccording to a Phase 3 trial published in The Lancet Diabetes & Endocrinology, a once-weekly combination of semaglutide and insulin icodec was...
Consuming more protein may protect patients taking anti-obesity drug from muscle loss: Study Dr. Kamal Kant Kohli24 July 2025 8:30 PM ISTWomen and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent...
